ARLINGTON, VA – (November 9, 2020) – Privia Medical Group – Gulf Coast (Privia), in partnership with Javara, announced our participation in a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study, developed by AstraZeneca will research a vaccine candidate intended to protect against the SARS-CoV-2 novel coronavirus. The …
More: Featured Gulf Coast
14
Sep
Sep
Achieves improved patient care outcomes and lower costs for Houston and South Texas communities HOUSTON, TX – (September 15, 2020) – Privia Medical Group–Gulf Coast announced that its accountable care organization (ACO), Privia Quality Network–Gulf Coast, achieved more than $5 million in shared savings through the Medicare Shared Savings Program (MSSP). The Privia Quality Network–Gulf …
13
Nov
Nov
ARLINGTON, VA – (November 13, 2019) — Javara and Privia Health, one of the nation’s fastest growing primary care focused medical groups providing value-based care to its patients, are aligning to offer industry-sponsored clinical trials to Privia Medical Group – Gulf Coast and Privia Medical Group – Georgia patients. Privia Health is a national physician …
30
Sep
Sep
Privia Quality Network–Gulf Coast Ranks as a Top-Performing ACO in First Performance Year
